LBPH Aug 2024 17.500 put
OPR - OPR Delayed price. Currency in USD
Add to watchlist
At close: 10:30AM EDT
Loading interactive chart…
- Simply Wall St.
Longboard Pharmaceuticals (NASDAQ:LBPH) Is In A Good Position To Deliver On Growth Plans
We can readily understand why investors are attracted to unprofitable companies. Indeed, Longboard Pharmaceuticals...
- Business Wire
Longboard Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
LA JOLLA, Calif., May 06, 2024--Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, today announced the grant of inducement awards to seven new employees. The Compensation Committee of the Board of Directors of Longboard approved the grants of non-qualified stock options to purchase an aggregate of 178,000 shares of its common stock (the "Common Stock") as inducements material
- GuruFocus.com
Longboard Pharmaceuticals Inc. (LBPH) Q1 2024 Earnings: Financial and Strategic Developments
Insight into Longboard Pharmaceuticals' First Quarter Performance and Future Outlook
© 2024 Yahoo. All rights reserved.